511 filings
Page 19 of 26
10-Q
2017 Q2
BNKL
Bionik Laboratories Corp.
Quarterly report
14 Nov 16
12:00am
8-K
BNKL
Bionik Laboratories Corp.
1 Nov 16
Regulation FD Disclosure
12:00am
8-K
BNKL
Bionik Laboratories Corp.
27 Oct 16
Bionik Laboratories Provides Corporate Update and Business Outlook
12:00am
S-1/A
BNKL
Bionik Laboratories Corp.
IPO registration (amended)
30 Sep 16
12:00am
3
BNKL
Bionik Laboratories Corp.
23 Sep 16
Bionik Laboratories / Timothy A. McCarthy McCarthy ownership change
12:00am
8-K
BNKL
Bionik Laboratories Corp.
23 Aug 16
Unregistered Sales of Equity Securities
12:00am
8-K
BNKL
Bionik Laboratories Corp.
17 Aug 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
BNKL
Bionik Laboratories Corp.
16 Aug 16
Bionik Laboratories Reports First Quarter Fiscal Year 2017 Financial Results and Provides Business Update
12:00am
10-Q
2017 Q1
BNKL
Bionik Laboratories Corp.
Quarterly report
15 Aug 16
12:00am
S-1
BNKL
Bionik Laboratories Corp.
IPO registration
10 Aug 16
12:00am
8-K
BNKL
Bionik Laboratories Corp.
8 Aug 16
Bionik Laboratories Appoints Timothy A. McCarthy as Chief Commercialization Officer and Expands Commercial Team
12:00am
UPLOAD
BNKL
Bionik Laboratories Corp.
3 Aug 16
Letter from SEC
12:00am
S-1/A
BNKL
Bionik Laboratories Corp.
IPO registration (amended)
19 Jul 16
12:00am
DEF 14A
BNKL
Bionik Laboratories Corp.
Definitive proxy
12 Jul 16
12:00am
8-K/A
BNKL
Bionik Laboratories Corp.
6 Jul 16
Unregistered Sales of Equity Securities
12:00am
PRE 14A
BNKL
Bionik Laboratories Corp.
1 Jul 16
Preliminary proxy
12:00am
8-K
BNKL
Bionik Laboratories Corp.
30 Jun 16
Bionik Laboratories Reports Fiscal Year Ended 2016 Financial Results and Provides Business Update
12:00am
10-KT
BNKL
Bionik Laboratories Corp.
30 Jun 16
Annual report (with FYE transition)
12:00am
8-K
BNKL
Bionik Laboratories Corp.
24 Jun 16
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
UPLOAD
BNKL
Bionik Laboratories Corp.
7 Jun 16
Letter from SEC
12:00am